Tarsus to Join Upcoming Investor Conferences

Tarsus Pharmaceuticals, Inc., headquartered in Irvine, California and traded on NASDAQ under the ticker TARS, is dedicated to addressing unmet medical needs by leveraging proven science and cutting-edge technology, initially focusing on eye care. The company has announced its management team’s participation in several upcoming investor conferences.

The first event is the William Blair Growth Stock Conference, where Jeff Farrow, Chief Financial and Chief Strategy Officer, will engage in an in-person fireside discussion scheduled for Tuesday, June 4, 2024, at 1:20 p.m. PT / 4:20 p.m. ET.

Following that, Jeff Farrow, joined by Aziz Mottiwala, Chief Commercial Officer, will attend the Jefferies Global Healthcare Conference. Their in-person fireside chat is set for Wednesday, June 5, 2024, at 12 p.m. PT / 3 p.m. ET.

Lastly, the company will be represented at the Goldman Sachs Global Healthcare Conference by Bobak Azamian, M.D., Ph.D., Chief Executive Officer and Chairman, alongside Jeff Farrow. This session is planned for Monday, June 10, 2024, at 11 a.m. PT / 2 p.m. ET.

All the fireside chats will be broadcast live, and the webcasts can be accessed through the events section of the Tarsus website. Recordings of these sessions will be available on the site within 48 hours post-event and will remain accessible for a limited duration.

Tarsus Pharmaceuticals, Inc. is committed to transforming patient care by developing innovative treatments. The company’s lead product, XDEMVY® (lotilaner ophthalmic solution) 0.25%, has received FDA approval in the United States for the treatment of Demodex blepharitis. Tarsus is also advancing its pipeline with several investigational therapies: TP-03 for Meibomian Gland Disease, TP-04 for rosacea, and TP-05, an oral tablet aimed at preventing Lyme disease. All these therapies are currently in Phase 2 of clinical development.

The company remains dedicated to revolutionizing patient care across various therapeutic categories, including eye care, dermatology, and infectious disease prevention.